You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 12, 2025

Details for Patent: 12,090,190


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 12,090,190 protect, and when does it expire?

Patent 12,090,190 protects NOCTIVA and is included in one NDA.

This patent has seventy-four patent family members in nineteen countries.

Summary for Patent: 12,090,190
Title:Safe desmopressin administration
Abstract:Disclosed is a family of intranasal spray dispensers for administering uniform low doses of desmopressin so as to achieve safe antidiuresis in human patients. The dispensers of the invention may be used in the treatment of nocturia, primary nocturnal enuresis, incontinence, urinary frequency, diabetes insipidus, or any disease or syndrome where desmopressin therapy is useful or where safe temporary suppression of urine production may lead to beneficial health effects or increased convenience in voiding control.
Inventor(s):Seymour Fein
Assignee:Acerus Pharmaceuticals USA LLC
Application Number:US17/885,368
Patent Claim Types:
see list of patent claims
Patent landscape, scope, and claims:

Understanding the Scope and Claims of a US Patent: A Detailed Analysis of United States Patent 12,090,190

Introduction to US Patents and the USPTO

The United States Patent and Trademark Office (USPTO) is the agency responsible for granting U.S. patents and registering trademarks. Understanding the scope and claims of a patent is crucial for both inventors and businesses to protect their intellectual property and navigate the complex patent landscape[1].

The Importance of Claim Scope in Patent Applications

When drafting a patent application, the scope of the claims is a critical aspect. A common misconception is that broader claims are always better, but this is not the case. Broader claims can be more difficult to get granted and are easier to invalidate. The claim scope must be balanced to ensure it is anchored to the embodiments in the disclosure without being overly broad[2].

Avoiding Overly Broad Claims

Overly broad claims can lead to invalidation due to the abstract idea exception or failure to meet the written description requirement. For example, the Federal Circuit court has ruled that claims directed to abstract ideas or results without specific means or methods are not patentable. This was illustrated in cases such as Yu v. Apple Inc. and Minerva Surgical, Inc. v. Hologic, Inc.[2].

Metrics for Measuring Patent Scope

Research has shown that narrower claims are associated with a higher probability of grant and a shorter examination process. Metrics such as independent claim length and independent claim count can be used to measure patent scope. These metrics have explanatory power for correlates of patent scope, including patent maintenance payments, forward citations, and the breadth of patent classes[4].

Analyzing United States Patent 12,090,190

To analyze the scope and claims of United States Patent 12,090,190, one must delve into the specifics of the patent.

Patent Details

  • Patent Title and Abstract: Understanding the title and abstract provides a general overview of the invention.
  • Claims: The claims section is where the legal boundaries of the invention are defined. Each claim must be clear, concise, and supported by the specification.
  • Specification: This section describes the invention in detail, including drawings and examples.

Claim Structure

  • Independent Claims: These claims stand alone and define the invention without reference to other claims.
  • Dependent Claims: These claims refer back to and further limit the independent claims.

Prior Art and Novelty

  • Prior Art Search: Conducting a thorough prior art search using tools like the USPTO's Patent Public Search, Global Dossier, and other international databases is essential to ensure the novelty of the invention[5].
  • Citations and References: Analyzing citations and references in the patent can provide insights into the existing state of the art and how the invention differs.

The Role of the USPTO in Patent Examination

The USPTO plays a crucial role in the examination process, ensuring that patents meet the requirements of novelty, non-obviousness, and utility.

Examination Process

  • Office Actions: During the examination process, the USPTO may issue office actions that require the applicant to narrow or clarify the claims.
  • Patent Examination Data System (PEDS): This system provides public access to bibliographic data for all publicly available patent applications, which can be useful in tracking the examination process[5].

Potential Challenges and Considerations

Invalidation Risks

  • Abstract Idea Exception: Claims that are too broad and directed to abstract ideas can be invalidated.
  • Written Description Requirement: Claims must be supported by the specification to avoid invalidation[2].

Litigation and Licensing

  • Litigation Costs: Overly broad claims can lead to increased litigation costs.
  • Licensing: Narrower, well-defined claims can make licensing negotiations clearer and more effective[4].

International Patent Landscape

Understanding the global patent landscape is crucial, especially if the invention has international implications.

Searching International Patent Offices

  • European Patent Office (EPO): Using databases like esp@cenet to search European patents.
  • Japan Patent Office (JPO): Searching Japanese patents with machine translation capabilities.
  • World Intellectual Property Organization (WIPO): Utilizing PATENTSCOPE for international patent applications[5].

Key Takeaways

  • Balanced Claim Scope: Ensure claims are neither too broad nor too narrow.
  • Thorough Prior Art Search: Conduct a comprehensive search to establish novelty.
  • Clear Specification: The specification must support the claims.
  • International Considerations: Understand the global patent landscape.

FAQs

What is the role of the USPTO in patent examination?

The USPTO is responsible for ensuring that patents meet the requirements of novelty, non-obviousness, and utility through the examination process.

Why is it important to avoid overly broad claims?

Overly broad claims can be easier to invalidate and may not provide the desired protection due to the abstract idea exception or failure to meet the written description requirement.

How can I measure the scope of a patent?

Metrics such as independent claim length and independent claim count can be used to measure patent scope and have explanatory power for several correlates of patent scope.

What resources are available for searching prior art?

Resources include the USPTO's Patent Public Search, Global Dossier, and databases from other international intellectual property offices like the EPO, JPO, and WIPO.

What are the risks of overly broad claims in litigation?

Overly broad claims can lead to increased litigation costs and a higher risk of invalidation.

Sources

  1. U.S. Patent and Trademark Office (USPTO) - USAGov https://www.usa.gov/agencies/u-s-patent-and-trademark-office
  2. The Importance of Getting the Claim Scope Right in a US Patent Application - Rimon Law https://www.rimonlaw.com/the-importance-of-getting-the-claim-scope-right-in-a-us-patent-application-i/
  3. U.S. Patent Small Claims Court - ACUS https://www.acus.gov/research-projects/us-patent-small-claims-court
  4. Patent Claims and Patent Scope - SSRN https://papers.ssrn.com/sol3/papers.cfm?abstract_id=2844964
  5. Search for patents - USPTO https://www.uspto.gov/patents/search

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 12,090,190

Showing 1 to 2 of 2 entries

International Family Members for US Patent 12,090,190

CountryPatent NumberEstimated ExpirationSupplementary Protection CertificateSPC CountrySPC Expiration
Australia 2009330203 ⤷  Try for Free
Australia 2010260211 ⤷  Try for Free
Australia 2015261630 ⤷  Try for Free
>Country>Patent Number>Estimated Expiration>Supplementary Protection Certificate>SPC Country>SPC Expiration
Showing 1 to 3 of 3 entries

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.